NYU Grossman Long Island School of Medicine Program

The NYU Grossman Long Island School of Medicine offers a distinguished Oncology and Hematology Fellowship, designed for aspiring hematologists and oncologists to gain in-depth clinical knowledge and experience in managing both solid and liquid tumors as well as hematologic disorders. This three-year, ACGME-accredited fellowship program is situated in Mineola, New York, providing a unique academic environment within the framework of a tuition-free medical school that started in 2019. The program is committed to cultivating a diverse community of medical professionals adept in screening, diagnosing, and treating a broad spectrum of cancers, while also addressing classical hematological disorders.

Fellowship Structure

Each year, the program accommodates three fellows, focusing on rigorous clinical training alongside research opportunities. The structure of the fellowship ensures that fellows partake in extensive patient experiences under the supervision of dedicated faculty members who are double board-certified in hematology and oncology. This interdisciplinary training allows fellows to gain comprehensive knowledge and skills that are vital for independent practice in the specialty3.

First-Year Experience

Fellows start their training with a focus on inpatient clinical care, dedicating seven months to the inpatient service while also engaging in subspecialty outpatient electives. By the end of the first year, fellows are required to present their research proposals to a faculty committee, fostering an early commitment to scholarly activity2.

Second-Year Experience

During the second year, the fellows transition to a mainly outpatient clinical setting, participating in various subspecialty clinics. This year emphasizes the continuation of their research efforts while allowing further development of clinical expertise3.

Third-Year Experience

The third year solidifies the fellows' outpatient experience and offers leadership opportunities as they mentor junior fellows. Research is emphasized, with designated months for conducting scholarly projects and electives in advanced topics, such as pediatric oncology and molecular methods3.

Curriculum Highlights

The curriculum is comprehensive, featuring both didactic and clinical components. Weekly teaching conferences, grand rounds, tumor board meetings, a core summer orientation series, and simulation training form the crux of the educational program. Notably, resources for clinical trials and research mentorship are integral, supporting fellows in their scholarly pursuits2.

Research Opportunities

Fellows engage in various research activities, often presenting their findings at national meetings, such as ASCO and ASH, and publishing in peer-reviewed journals. Diverse faculty research interests offer an expansive avenue for fellows to develop original projects, including areas like immunotherapy and tumor biology3.

Training Sites

The fellowship primarily operates out of NYU Langone Hospital—Long Island and the Perlmutter Cancer Center. Facilities feature a state-of-the-art infusion center and dedicated inpatient units for comprehensive patient care. Fellows have the opportunity to work with substantial pathology volumes, gaining exposure to over 2,000 cancer cases diagnosed annually2.

Visa Support and Competitiveness

The program is open to applicants on J-1 visas, ensuring support for international medical graduates (IMGs) looking to pursue training in hematology and oncology. This fellowship program is regarded as competitive, and applicants are typically required to have completed three years of ACGME-accredited internal medicine residency training1.

Unique Aspects of the Program

One distinctive feature of the fellowship is its emphasis on wellness and team-building activities, promoting a supportive environment that values fellow feedback and nurtures personal and professional growth. The program is designed not only to advance clinical skills but also to enhance communication and teamwork in professional settings1.